Insulet’s Omnipod 5 now compatible with Abbott’s FreeStyle Libre 2 Plus
- Insulet (NASDAQ:PODD) said its Omnipod 5 automated insulin delivery system is now compatible with Abbott Laboratories’ (ABT) FreeStyle Libre 2 Plus continuous glucose monitor sensor in the U.S.
- The FDA approved Omnipod 5 for the treatment of type 2 diabetes in adults in August. The product is also approved for type 1 diabetes.